Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • FRAUD AND ABUSE—1st Cir.: No violation of constitutional rights where provider repeatedly requested to proceed pro se
    • ANTITRUST—E.D. Pa.: Summary judgment denied drug manufacturers in Niaspan® pay-for-delay litigation
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • EXPERT INSIGHTS—Peptides First, Paperwork Later: HHS Clears Six For Compounding Ahead Of Bulks List Rulemaking
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FEDERAL LEGISLATION NEWS—AI-Enabled Hacking Fuels Need to Renew Cyber Info-Sharing Law, Business Groups Say
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • GENERAL HEALTH CARE NEWS—FDA GUIDANCE NOTICES: FDA issues guidance on risk reduction of transfusion transmitted hepatitis B
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • HEALTH CARE EMPLOYMENT ISSUES—N.D. Ill.: Nurse forced to re-apply for job after hospital acquisition signed an enforceable arbitration agreement
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICAL DEVICES—FINAL RULES: FDA classifies certain radiology software
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—E.D. Mo.: West Virginia Pharmacy Audit Integrity Act does not provide a private right of action
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRODUCTS LIABILITY (DEVICES)—D. Ariz.: Claims against Bard proceed to bellwether trial in patient’s implant injury case
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, EXPERT INSIGHTS—Peptides First, Paperwork Later: HHS Clears Six For Compounding Ahead Of Bulks List Rulemaking, (Nov 4, 2026)

    Law Firms Mentioned:McDermott Will & Schulte

    By Monica R. Chmielewski, Kyle Y. Faget, Patrick Zanayed, Emica Kim, Jae Hyun Lee, Grayson I. Dimick, Marshall E. Jackson, Jr., Paul Gadiock, James Ravitz and Jayda Greco of McDermott Will & Schulte

    Overview

    On October 28, 2026, the US Department of Health and Human Services (HHS) issued an interim policy under which it does not intend to take enforcement action against state-licensed pharmacies, federal facilities, or licensed physicians that co ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use